Skip to main content
Top
Published in: Obesity Surgery 10/2018

01-10-2018 | Original Contributions

Mid-term 4-Year Outcomes with Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy Surgery at a Single US Center

Authors: Hinali Zaveri, Amit Surve, Daniel Cottam, Austin Cottam, Walter Medlin, Christina Richards, LeGrand Belnap, Samuel Cottam, Benjamin Horsley

Published in: Obesity Surgery | Issue 10/2018

Login to get access

Abstract

Background

Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) is a modification of Roux-en-Y duodenal switch (RYDS). Long-term data on this operation is lacking in the literature. We reviewed our mid-term data of this RYDS modification.

Purpose

To analyze the outcomes with SADI-S at 4 years.

Methods

Data from patients who underwent a primary SADI-S procedure performed by three surgeons at a single institution from June 2013 through February 2018 were retrospectively reviewed. All revision bariatric surgeries were excluded. Regression analyses were performed for all follow-up weight loss data.

Results

There were 437 patients in our database. The pre-operative mean body mass index (BMI) was 49.8 ± 8.8 kg/m2. The 30-day complication rate was 7.7%. The 30-day readmission, reoperation, and mortality rates were 1.8, 1.3, and 0.2%, respectively. The long-term complication rate was 10.9%. Seventy-nine patients were 4 years post SADI-S surgery and follow-up was possible for 44 patients (55.7%). At 4 years, patients had an average change in BMI of 18.1 ± 6 units with an excess weight loss (EWL) of 85.7 ± 27.3%. At 4 years, 97.6% patients were able to maintain HbA1c < 6% with or without the use of diabetic medication. There was a statistically significant difference between most of the pre-operative and post-operative nutritional data.

Conclusions

SADI-S is a safe and effective procedure in both short- and mid-term data points. Diabetes resolution and weight loss appear similar to traditional RYDS and better than RYGB.
Literature
1.
go back to reference Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.CrossRefPubMed Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.CrossRefPubMed
2.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed
3.
go back to reference Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26(9):2098–104.CrossRefPubMed Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26(9):2098–104.CrossRefPubMed
4.
go back to reference Surve A, Zaveri H, Cottam D. A safer and simpler technique of duodenal dissection and transection of the duodenal bulb for duodenal switch. Surg Obes Relat Dis. 2016;12(4):923–4.CrossRefPubMed Surve A, Zaveri H, Cottam D. A safer and simpler technique of duodenal dissection and transection of the duodenal bulb for duodenal switch. Surg Obes Relat Dis. 2016;12(4):923–4.CrossRefPubMed
5.
go back to reference Surve A, Zaveri H, Cottam D, et al. A retrospective comparison of biliopancreatic diversion with duodenal switch with single anastomosis duodenal switch (SIPS-stomach intestinal pylorus sparing surgery) at a single institution with two year follow-up. Surg Obes Relat Dis. 2017;13(3):415–22.CrossRefPubMed Surve A, Zaveri H, Cottam D, et al. A retrospective comparison of biliopancreatic diversion with duodenal switch with single anastomosis duodenal switch (SIPS-stomach intestinal pylorus sparing surgery) at a single institution with two year follow-up. Surg Obes Relat Dis. 2017;13(3):415–22.CrossRefPubMed
6.
go back to reference Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22(9):947–54.CrossRefPubMed Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22(9):947–54.CrossRefPubMed
7.
go back to reference Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17(12):1614–8.CrossRefPubMed Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17(12):1614–8.CrossRefPubMed
8.
go back to reference Nightingale J, Woodward JM. Guidelines for management of patients with short bowel. Gut. 2006;55(Suppl 4):v1–12. Nightingale J, Woodward JM. Guidelines for management of patients with short bowel. Gut. 2006;55(Suppl 4):v1–12.
9.
go back to reference Brown WA, Ooi G, Higa K, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO position statement. Obes Surg. 2018;28:1207–16.CrossRefPubMed Brown WA, Ooi G, Higa K, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO position statement. Obes Surg. 2018;28:1207–16.CrossRefPubMed
10.
go back to reference Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720–6.CrossRefPubMed Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20(12):1720–6.CrossRefPubMed
12.
go back to reference Sanchez-Pernaute A, Rubio MA, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092–8.CrossRefPubMed Sanchez-Pernaute A, Rubio MA, Cabrerizo L, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients. Surg Obes Relat Dis. 2015;11(5):1092–8.CrossRefPubMed
13.
go back to reference Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. In: Surg Obes Relat Dis, vol. 14; 2018. p. 594–601. Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. In: Surg Obes Relat Dis, vol. 14; 2018. p. 594–601.
14.
go back to reference Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data. Surg Obes Relat Dis. 2016;12(9):1697–705.CrossRefPubMed Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch: 2-, 5-, and 10-year data. Surg Obes Relat Dis. 2016;12(9):1697–705.CrossRefPubMed
15.
go back to reference Biertho L, Lebel S, Marceau S, et al. Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis. 2013;9(1):63–8.CrossRefPubMed Biertho L, Lebel S, Marceau S, et al. Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis. 2013;9(1):63–8.CrossRefPubMed
16.
go back to reference Obied N, Malick W, Concors S, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10-13 year data. Surg Obes Relat Dis. 2016;12(1):11–20.CrossRef Obied N, Malick W, Concors S, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10-13 year data. Surg Obes Relat Dis. 2016;12(1):11–20.CrossRef
17.
go back to reference Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1040 patients. What have we learned? Obes Surg. 2000;10:509–13.CrossRefPubMed Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1040 patients. What have we learned? Obes Surg. 2000;10:509–13.CrossRefPubMed
18.
go back to reference Marceau P, Biron S, Marceau S, et al. Biliopancreatic diversion duodenal switch: independent contributions of sleeve resection and duodenal exclusion. Obes Surg. 2014;24:1843–9.CrossRefPubMed Marceau P, Biron S, Marceau S, et al. Biliopancreatic diversion duodenal switch: independent contributions of sleeve resection and duodenal exclusion. Obes Surg. 2014;24:1843–9.CrossRefPubMed
19.
go back to reference Cottam A, Cottam D, Roslin M, et al. A matched cohort analysis of sleeve gastrectomy with and without 300 cm loop duodenal switch with 18-month follow-up. Obes Surg. 2016;26(10):2363–9.CrossRefPubMed Cottam A, Cottam D, Roslin M, et al. A matched cohort analysis of sleeve gastrectomy with and without 300 cm loop duodenal switch with 18-month follow-up. Obes Surg. 2016;26(10):2363–9.CrossRefPubMed
20.
go back to reference Surve A, Zaveri H, Cottam D, et al. Mid-term outcomes of gastric bypass weight loss failure to duodenal switch. Surg Obes Relat Dis. 2016;12(9):1663–70.CrossRefPubMed Surve A, Zaveri H, Cottam D, et al. Mid-term outcomes of gastric bypass weight loss failure to duodenal switch. Surg Obes Relat Dis. 2016;12(9):1663–70.CrossRefPubMed
22.
go back to reference Goldner Ws SJA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized, pilot clinical trial. Obes Surg. 2009;19:173–9.CrossRefPubMed Goldner Ws SJA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized, pilot clinical trial. Obes Surg. 2009;19:173–9.CrossRefPubMed
23.
go back to reference Einarsdottir K, Preen DB, Clay TD, et al. Effect of a single “megadose” intramuscular vitamin D (600000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg. 2010;20:732–7.CrossRefPubMed Einarsdottir K, Preen DB, Clay TD, et al. Effect of a single “megadose” intramuscular vitamin D (600000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg. 2010;20:732–7.CrossRefPubMed
24.
go back to reference Dolan K, Hatzifotis M, Newbury L, et al. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg. 2004;240:51–6.CrossRefPubMedPubMedCentral Dolan K, Hatzifotis M, Newbury L, et al. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg. 2004;240:51–6.CrossRefPubMedPubMedCentral
25.
go back to reference Abd-Elatif A, Yousser T, Farid M, et al. Nutritional markers after loop duodenal switch (SADI-S) for morbid obesity: a technique with favorable nutritional outcome. J Obes Weight Loss Ther. 2015;5(3):1000268. Abd-Elatif A, Yousser T, Farid M, et al. Nutritional markers after loop duodenal switch (SADI-S) for morbid obesity: a technique with favorable nutritional outcome. J Obes Weight Loss Ther. 2015;5(3):1000268.
26.
go back to reference Surve A, Zaveri H, Cottam D. Retrograde filling of the afferent limb as a cause of chronic nausea after single anastomosis loop duodenal switch. Surg Obes Relat Dis. 2016;12(4):e39–42.CrossRefPubMed Surve A, Zaveri H, Cottam D. Retrograde filling of the afferent limb as a cause of chronic nausea after single anastomosis loop duodenal switch. Surg Obes Relat Dis. 2016;12(4):e39–42.CrossRefPubMed
27.
go back to reference Zhang H, Han X, Yu H, Di J, Zhang P, Jia W. Effect of Roux-en-Y gastric bypass on remission of T2D: medium-term follow-up in Chinese patients with different BMI obesity class. Obes Surg 2016:1–9. Zhang H, Han X, Yu H, Di J, Zhang P, Jia W. Effect of Roux-en-Y gastric bypass on remission of T2D: medium-term follow-up in Chinese patients with different BMI obesity class. Obes Surg 2016:1–9.
28.
go back to reference Purnell JQ, Selzer F, Wahed AS, et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the longitudinal assessment of bariatric surgery study. Diabetes Care. 2016;39(7):1101–7.CrossRefPubMedPubMedCentral Purnell JQ, Selzer F, Wahed AS, et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the longitudinal assessment of bariatric surgery study. Diabetes Care. 2016;39(7):1101–7.CrossRefPubMedPubMedCentral
29.
go back to reference Sjostrom L, Peltonen M, Jacobsen P, et al. Association of bariatric surgery with long term remission of type 2 diabetes with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed Sjostrom L, Peltonen M, Jacobsen P, et al. Association of bariatric surgery with long term remission of type 2 diabetes with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed
30.
go back to reference Bretheur SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured. Long term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37. Bretheur SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured. Long term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37.
31.
go back to reference Digiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long term follow-up. Surg Obes Relat Dis. 2010;6(3):254–9.CrossRef Digiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long term follow-up. Surg Obes Relat Dis. 2010;6(3):254–9.CrossRef
32.
go back to reference Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRefPubMedPubMedCentral Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017;376:641–51.CrossRefPubMedPubMedCentral
33.
go back to reference Roslin MS, Gagner M, Goriparthi R, et al. The rationale for a duodenal switch as the primary surgical treatment of advanced type 2 diabetes mellitus and metabolic disease. Surg Obes Relat Dis. 2015;11:704–10.CrossRefPubMed Roslin MS, Gagner M, Goriparthi R, et al. The rationale for a duodenal switch as the primary surgical treatment of advanced type 2 diabetes mellitus and metabolic disease. Surg Obes Relat Dis. 2015;11:704–10.CrossRefPubMed
34.
go back to reference Marceau P, Biron S, Marceau S, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015;25:1584–93.CrossRefPubMed Marceau P, Biron S, Marceau S, et al. Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion. Obes Surg. 2015;25:1584–93.CrossRefPubMed
35.
go back to reference Scopinaro N. Biliopancreatic diversion: mechanisms of action and long term results. Obes Surg. 2006;16:683–9.CrossRefPubMed Scopinaro N. Biliopancreatic diversion: mechanisms of action and long term results. Obes Surg. 2006;16:683–9.CrossRefPubMed
Metadata
Title
Mid-term 4-Year Outcomes with Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy Surgery at a Single US Center
Authors
Hinali Zaveri
Amit Surve
Daniel Cottam
Austin Cottam
Walter Medlin
Christina Richards
LeGrand Belnap
Samuel Cottam
Benjamin Horsley
Publication date
01-10-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 10/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3358-x

Other articles of this Issue 10/2018

Obesity Surgery 10/2018 Go to the issue